A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection. [electronic resource]
Producer: 20120405Description: 1215-21 p. digitalISSN:- 1600-0641
- Adult
- Antiviral Agents -- adverse effects
- DNA, Viral -- blood
- Female
- Hepatitis B Antibodies -- administration & dosage
- Hepatitis B Surface Antigens -- blood
- Hepatitis B Vaccines -- administration & dosage
- Hepatitis B e Antigens -- blood
- Hepatitis B, Chronic -- complications
- Humans
- Infant
- Infant, Newborn
- Infectious Disease Transmission, Vertical -- prevention & control
- Male
- Nucleosides -- adverse effects
- Pregnancy
- Pregnancy Complications, Infectious -- drug therapy
- Prospective Studies
- Pyrimidinones -- adverse effects
- Telbivudine
- Thymidine -- analogs & derivatives
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.